IKCS 2022: The New Era of Clinical Trials: Meeting Regulatory Requirements and Decreasing Barriers
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology
Current Oncology | Free Full-Text | CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
PDF) Patient-reported outcomes: A new era in clinical research
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
Circulation: Heart Failure | AHA/ASA Journals
Frontiers | Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
Digital clinical trials: a new era - LaingBuisson News
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM
PDF) Patient-reported outcomes: A new era in clinical research
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
Patient-Reported Outcomes | Rethinking Clinical Trials®
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium - The Lancet Oncology
COVID-19 Opens a New Era for Real-World Evidence in Pharma | BCG
The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders | Journal of Patient-Reported Outcomes | Full Text
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease - ScienceDirect
